CIK 0001933567 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Neuraxis, INC
Sign in to watch- Ticker
- NRXS
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455079684
- Phone
- (812) 689-0791
- Business address
- 11611 N. MERIDIAN ST, SUITE 330, CARMEL, IN, 46032
- Open-market buys, last 90 days
- $12,260
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$12,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | Carrico Brian Allen Chief Executive Officer | Purchase | +268 | $4.84 | $1K | 227,604 |
| 2026-10-08 | Carrico Thomas Joeseph CRO, CCO, CPO | Purchase | +328 | $4.84 | $2K | 199,673 |
| 2026-10-08 | Henrichs Timothy Robert Chief Financial Officer | Purchase | +1,937 | $4.84 | $9K | 9,530 |
| 2026-08-24 | Miranda Adrian CMO, SVP Science & Tech | Grant or award | +199,106 | 199,106 | ||
| 2026-08-24 | Miranda Adrian CMO, SVP Science & Tech | Conversion · Stock Options | −337,204 | $6.94 | $2.3M | 0 |
| 2026-08-24 | Miranda Adrian CMO, SVP Science & Tech | Grant or award · RSU | +337,204 | 337,204 | ||
| 2026-08-24 | Miranda Adrian CMO, SVP Science & Tech | Conversion · RSU | −337,204 | 0 | ||
| 2026-08-24 | Carrico Thomas Joeseph CRO, CCO, CPO | Grant or award | +193,678 | 199,345 | ||
| 2026-08-24 | Carrico Thomas Joeseph CRO, CCO, CPO | Conversion · Stock Options | −306,236 | $6.94 | $2.1M | 0 |
| 2026-08-24 | Carrico Thomas Joeseph CRO, CCO, CPO | Grant or award · RSU | +306,236 | 306,236 | ||
| 2026-08-24 | Carrico Thomas Joeseph CRO, CCO, CPO | Conversion · RSU | −306,236 | 0 | ||
| 2026-08-24 | Carrico Brian Allen Chief Executive Officer | Grant or award | +199,188 | 227,336 | ||
| 2026-08-24 | Carrico Brian Allen Chief Executive Officer | Conversion · Stock Options | −320,000 | $6.94 | $2.2M | 0 |
| 2026-08-24 | Carrico Brian Allen Chief Executive Officer | Grant or award · RSU | +320,000 | 320,000 | ||
| 2026-08-24 | Carrico Brian Allen Chief Executive Officer | Conversion · RSU | −320,000 | 0 | ||
| 2026-08-13 | Watkins Bradley Mitchell Director | Grant or award | +26,073 | $6.28 | $164K | 72,408 |
| 2026-08-13 | Miranda Adrian CMO, SVP Science & Tech | Grant or award · RSU | +133,341 | $6.28 | $837K | 133,341 |
| 2026-08-13 | Keyser Jane Elizabeth Director | Grant or award | +26,073 | $6.28 | $164K | 72,408 |
| 2026-08-13 | Henrichs Timothy Robert Chief Financial Officer | Grant or award · RSU | +141,479 | $6.28 | $888K | 141,479 |
| 2026-08-13 | Ferge Kristin A Director | Grant or award | +31,134 | $6.28 | $196K | 67,072 |
Page 1 of 4 · 79 trades